Microbial Genomics as a Guide to Drug Discovery and Structural Elucidation:  ECO-02301, a Novel Antifungal Agent, as an Example†

2005 ◽  
Vol 68 (4) ◽  
pp. 493-496 ◽  
Author(s):  
James B. McAlpine ◽  
Brian O. Bachmann ◽  
Mahmood Piraee ◽  
Steve Tremblay ◽  
Anne-Marie Alarco ◽  
...  
2016 ◽  
Vol 72 (a1) ◽  
pp. s24-s24
Author(s):  
Ali Jazayeri ◽  
Andrew Doré ◽  
Daniel Lamb ◽  
Harini Krishnamurthy ◽  
Stacey Southall ◽  
...  

2015 ◽  
Vol 29 (21) ◽  
pp. 2083-2089 ◽  
Author(s):  
Marie Ahlqvist ◽  
Carina Leandersson ◽  
Martin A. Hayes ◽  
Ismael Zamora ◽  
Richard A. Thompson

1988 ◽  
Vol 41 (12) ◽  
pp. 1774-1779 ◽  
Author(s):  
ROBERT E. SCHWARTZ ◽  
JERROLD LIESCH ◽  
OTTO HENSENS ◽  
LAURETTA ZITANO ◽  
SUE HONEYCUTT ◽  
...  

1996 ◽  
Vol 61 (3) ◽  
pp. 1082-1100 ◽  
Author(s):  
Anthony G. M. Barrett ◽  
Michael Peña ◽  
J. Adam Willardsen

2018 ◽  
Vol 16 (28) ◽  
pp. 5065-5080 ◽  
Author(s):  
Helena Martin-Gómez ◽  
Judit Tulla-Puche

The diverse functionality and the extraordinary stability of lasso peptides make these molecules attractive scaffolds for drug discovery. The ability to generate lasso peptides chemically remains a challenging endeavor.


2002 ◽  
Vol 23 (5) ◽  
pp. 17
Author(s):  
Stuart L Hazell

Genomics represents a new tool in drug discovery. Microbial genomics have been at the forefront of a new era of whole cell molecular biology because genomic data provides a quantum leap in available genetic data. But while the tool is valuable and important, it is not the complete answer.


ChemInform ◽  
2010 ◽  
Vol 27 (27) ◽  
pp. no-no
Author(s):  
A. G. M. BARRETT ◽  
M. PENA ◽  
J. A. WILLARDSEN

Sign in / Sign up

Export Citation Format

Share Document